HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 72 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $315 | +53.7% | 107,500 | +50.1% | 0.00% | – |
| Q2 2023 | $205 | +39.5% | 71,600 | +50.1% | 0.00% | – |
| Q1 2023 | $147 | +194.0% | 47,700 | +100.4% | 0.00% | – |
| Q4 2022 | $50 | -100.0% | 23,800 | -88.6% | 0.00% | -100.0% |
| Q3 2022 | $678,000 | +1783.3% | 208,000 | +1773.9% | 0.00% | – |
| Q2 2022 | $36,000 | -89.2% | 11,100 | -76.4% | 0.00% | – |
| Q1 2022 | $333,000 | +211.2% | 47,100 | +218.2% | 0.00% | – |
| Q4 2021 | $107,000 | – | 14,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
| Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
| Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
| CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
| Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
| Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
| Sciencast Management LP | 26,300 | $182,000 | 0.04% |
| Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
| Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |